PD-0325901 Uses, Dosage, Side Effects and more
PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.
| Attribute | Details |
|---|---|
| Trade Name | PD-0325901 |
| Generic | PD-0325901 |
| Type | |
| Formula | C16H14F3IN2O4 |
| Weight | Average: 482.193 Monoisotopic: 481.995034981 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
